Agios Pharma (AGIO) Tops Q3 EPS by 3c; Reports Cash and Cash Equivalents of $1.4B

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.56), $0.03 better than the analyst estimate of ($1.59).

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Amtech Systems closes $60 million public stock offering
• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance